HealthcareLisata jumps on FDA orphan drug status for liver cancer drugBy Helitra.com·September 7, 2024·1 min read Lisata jumps on FDA orphan drug status for liver cancer drug Source: SeekingalphaADVERTISEMENT ADVERTISEMENTcancer drug FDA jumps Lisata liver orphan status Post navigation Previous storyAscendis raised to outperform by Oppenheimer ahead of drug launchNext storyEli Lilly bets $409M for AI-focused drug discovery
Fitness · HealthcareMenopause Changes Your Skin Completely — So Why Don’t Women Know It?November 4, 2026Your skin changes as you age: it’s a fact of life, and we all know it. But what most women don’t realize is…
Fitness · HealthcareMenopause Rewires Your Metabolism – Here’s What You Can Do About ItNovember 4, 2026You’ve probably heard that heart disease risk goes up after menopause. But the shift isn’t just about losing estrogen’s protective effects. Your body…
Fitness · HealthcareHow to Jump Rope for Beginners When You Keep TrippingNovember 4, 2026If you can run a mile but cannot clear a jump rope five times, start with the coordination problem. Practice one turn and…